There are often lengthy waits to get an appointment with a doctor but if you have one of these conditions you can dodge the ...
If allergies and sinus issues are disrupting your day, an ENT (ear, nose, and throat) specialist can offer targeted solutions to provide lasting relief. Here are some ways they can help: ...
Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...
The vaccine protects against serious infections including invasive diseases that attack parts of the body that are normally ...
Sinusitis often results from a viral infection, though bacteria or fungi can also be responsible. It may develop after experiencing a cold or dealing with allergies. This condition is quite common ...
WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company ...
WATERTOWN, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra” or the "Company”), a clinical-stage biotechnology company developing long-acting anti-inflammatory ...
GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this time in patients with chronic rhi ...
(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback